Many studies have demonstrated that blocking the interaction between p53 and MDM2 using MDM2 antagonists can trigger apoptotic signaling induced by p53 in NB (Van Maerken et al., 2006; Xue et al., 2007). The gene discussed is TP53; the disease is neuroblastoma.